Back
26
Also listed as
RMSYF
OTC
Day Range
$6.55
$6.98
52-Week Range
$4.31
$7.18
Volume
8
50D / 200D Avg
$6.52
/
$5.80
Prev Close
$6.98
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 267.3 | 0.2 |
| P/B | 1.3 | 3.0 |
| ROE % | 0.5 | 3.6 |
| Net Margin % | 0.1 | 3.8 |
| Rev Growth 5Y % | 8.3 | 9.7 |
| D/E | 2.4 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.46
$0.46 – $0.48
|
20.66B | 1 |
| FY2026 |
$0.40
$0.40 – $0.41
|
19.88B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | N/A | $0.11 | — |
| 2025-08-28 | N/A | $0.09 | — |
| 2025-02-27 | N/A | -$0.28 | — |
| 2024-08-29 | N/A | $0.38 | — |
| 2024-02-29 | N/A | $2.26 | — |
| 2023-06-30 | N/A | $0.30 | — |
| 2022-12-31 | N/A | $0.58 | — |
| 2022-06-30 | N/A | $0.35 | — |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
7.95%
Growth (3Y)
-12.52%
Growth (5Y)
4.10%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 10, 2026 | Apr 10, 2026 | $0.06 | 1.64% |
| Sep 08, 2025 | Oct 10, 2025 | $0.05 | 2.67% |
| Mar 10, 2025 | Apr 11, 2025 | $0.06 | 2.47% |
| Sep 09, 2024 | Oct 11, 2024 | $0.07 | 2.00% |
| Mar 11, 2024 | Apr 22, 2024 | $0.07 | 1.26% |
| Sep 05, 2023 | Oct 16, 2023 | $0.04 | 1.66% |
| Mar 03, 2023 | Apr 14, 2023 | $0.08 | 1.51% |
| Sep 02, 2022 | Oct 14, 2022 | $0.09 | 1.38% |
| Mar 04, 2022 | Apr 15, 2022 | $0.09 | 2.44% |
| Sep 03, 2021 | Oct 15, 2021 | $0.19 | 2.28% |
| Mar 05, 2021 | Apr 15, 2021 | $0.09 | 0.76% |
| Mar 06, 2020 | Apr 13, 2020 | $0.09 | 2.19% |
| Sep 11, 2019 | Oct 15, 2019 | $0.15 | 2.28% |
| Mar 08, 2019 | Apr 15, 2019 | $0.11 | 2.47% |
| Sep 07, 2018 | Oct 15, 2018 | $0.16 | 2.64% |
| Apr 27, 2018 | May 07, 2018 | $0.11 | 2.22% |
| Sep 08, 2017 | Oct 13, 2017 | $0.16 | 1.87% |
| Mar 03, 2017 | Apr 13, 2017 | $0.10 | 0.82% |
| Apr 07, 2016 | Apr 14, 2016 | $0.09 | 0.73% |
Key Takeaways
Revenue grew 8.27% annually over 5 years — modest growth
Earnings declined -97.30% over the past year
ROE of 0.48% is below average
Debt/Equity of 2.41 — high leverage
Generating 704.20M in free cash flow
P/E of 267.29 — premium valuation
Growth
Revenue Growth (5Y)
8.27%
Revenue (1Y)6.09%
Earnings (1Y)-97.30%
FCF Growth (3Y)10.32%
Quality
Return on Equity
0.48%
ROIC3.81%
Net Margin0.14%
Op. Margin4.93%
Safety
Debt / Equity
2.41
Current Ratio0.90
Interest Coverage2.60
Valuation
P/E Ratio
267.29
Forward P/E17.31
P/B Ratio1.28
EV/EBITDA20.39
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.09% | Revenue Growth (3Y) | 8.63% |
| Earnings Growth (1Y) | -97.30% | Earnings Growth (3Y) | -71.63% |
| Revenue Growth (5Y) | 8.27% | Earnings Growth (5Y) | -51.92% |
| Profitability | |||
| Revenue (TTM) | 17.67B | Net Income (TTM) | 24.00M |
| ROE | 0.48% | ROA | 0.11% |
| Gross Margin | 77.34% | Operating Margin | 4.93% |
| Net Margin | 0.14% | Free Cash Flow (TTM) | 704.20M |
| ROIC | 3.81% | FCF Growth (3Y) | 10.32% |
| Safety | |||
| Debt / Equity | 2.41 | Current Ratio | 0.90 |
| Interest Coverage | 2.60 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 7.95% |
| Dividend Growth (3Y) | -12.52% | Dividend Growth (5Y) | 4.10% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 267.29 | Forward P/E | 17.31 |
| P/B Ratio | 1.28 | P/S Ratio | 0.36 |
| PEG Ratio | -3.42 | Forward PEG | N/A |
| EV/EBITDA | 20.39 | Fwd EV/EBITDA | 7.72 |
| Forward P/S | 0.32 | Fwd Earnings Yield | 5.78% |
| FCF Yield | 10.98% | ||
| Market Cap | 6.42B | Enterprise Value | 17.75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.67B | 16.66B | 14.98B | 13.18B | 12.86B |
| Net Income | 24.00M | 888.70M | 298.10M | 274.00M | 449.00M |
| EPS (Diluted) | 0.03 | 0.97 | 0.31 | 0.29 | 0.48 |
| Gross Profit | 13.67B | 2.01B | 1.27B | 900.60M | 832.80M |
| Operating Income | 870.50M | 833.20M | 1.64B | 230.60M | 1.59B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 22.48B | 20.89B | 21.13B | 19.58B | 19.39B |
| Total Liabilities | 16.77B | 15.37B | 16.30B | 15.06B | 14.83B |
| Shareholders' Equity | 5.02B | 4.90B | 4.15B | 3.93B | 4.03B |
| Total Debt | 12.12B | 10.94B | 11.89B | 10.70B | 10.55B |
| Cash & Equivalents | 784.40M | 662.30M | 656.10M | 314.20M | 2.96B |
| Current Assets | 4.04B | 3.87B | 3.90B | 3.29B | 5.35B |
| Current Liabilities | 4.47B | 4.18B | 3.81B | 3.75B | 3.72B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#392 of 619
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026